Cimzia is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Ucb, Inc.. The primary component is Certolizumab Pe.
Product ID | 50474-710_119e849c-fc70-44d1-883f-1c977c869e17 |
NDC | 50474-710 |
Product Type | Human Prescription Drug |
Proprietary Name | Cimzia |
Generic Name | Certolizumab Pegol |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2009-05-14 |
Marketing Category | BLA / BLA |
Application Number | BLA125160 |
Labeler Name | UCB, Inc. |
Substance Name | CERTOLIZUMAB PE |
Active Ingredient Strength | 200 mg/mL |
Pharm Classes | Tumor Necrosis |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2009-05-14 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125160 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-05-14 |
Marketing Category | BLA |
Application Number | BLA125160 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-05-14 |
Marketing Category | BLA |
Application Number | BLA125160 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-05-14 |
Ingredient | Strength |
---|---|
CERTOLIZUMAB PEGOL | 200 mg/mL |
NDC | Brand Name | Generic Name |
---|---|---|
50474-700 | Cimzia | certolizumab pegol |
50474-710 | Cimzia | certolizumab pegol |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CIMZIA 86685372 4944726 Live/Registered |
UCB PHARMA, S.A. 2015-07-07 |
CIMZIA 85586588 4217932 Live/Registered |
UCB PHARMA, S.A. 2012-04-02 |
CIMZIA 79028492 3298318 Dead/Cancelled |
UCB PHARMA, S.A. 2006-06-22 |
CIMZIA 78229684 3248891 Live/Registered |
UCB PHARMA, S.A. 2003-03-25 |